These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 16137841)
1. In vitro effect of free and complexed indium(III) against Mycobacterium tuberculosis. David S; Barros V; Cruz C; Delgado R FEMS Microbiol Lett; 2005 Oct; 251(1):119-24. PubMed ID: 16137841 [TBL] [Abstract][Full Text] [Related]
2. Exploring Mycobacterium avium inhibition by macrocyclic compounds. David S; Barros V; Passos Guerra K; Delgado R Res Microbiol; 2005 Nov; 156(9):904-10. PubMed ID: 16024228 [TBL] [Abstract][Full Text] [Related]
3. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
4. Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages. Khan A; Sarkar S; Sarkar D Int J Antimicrob Agents; 2008 Jul; 32(1):40-5. PubMed ID: 18538548 [TBL] [Abstract][Full Text] [Related]
5. In vitro and ex vivo antimycobacterial potential of azole drugs against Mycobacterium tuberculosis H37Rv. Ahmad Z; Sharma S; Khuller GK FEMS Microbiol Lett; 2005 Oct; 251(1):19-22. PubMed ID: 16143463 [TBL] [Abstract][Full Text] [Related]
6. SILA 421, an inhibitor of efflux pumps of cancer cells, enhances the killing of intracellular extensively drug-resistant tuberculosis (XDR-TB). Martins M; Viveiros M; Ramos J; Couto I; Molnar J; Boeree M; Amaral L Int J Antimicrob Agents; 2009 May; 33(5):479-82. PubMed ID: 19155160 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro antitubercular activity of some 1-[(4-sub)phenyl]-3-(4-{1-[(pyridine-4-carbonyl)hydrazono]ethyl}phenyl)thiourea. Sriram D; Yogeeswari P; Madhu K Bioorg Med Chem Lett; 2006 Feb; 16(4):876-8. PubMed ID: 16303302 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization and antimycobacterial activity of Ag(I)-aspartame, Ag(I)-saccharin and Ag(I)-cyclamate complexes. Cavicchioli M; Leite CQ; Sato DN; Massabni AC Arch Pharm (Weinheim); 2007 Oct; 340(10):538-42. PubMed ID: 17912678 [TBL] [Abstract][Full Text] [Related]
9. [In-vitro activity of two hybrid synthetic peptides having antimicrobial activity against mycobacteria]. Zerbini E; Andreu D; Tonarelli G; Sequeira MD Rev Argent Microbiol; 2006; 38(4):221-3. PubMed ID: 17370578 [TBL] [Abstract][Full Text] [Related]
10. Bioactivity of pyridine-2-thiolato-1-oxide metal complexes: Bi(III), Fe(III) and Ga(III) complexes as potent anti-Mycobacterium tuberculosis prospective agents. Machado I; Marino LB; Demoro B; Echeverría GA; Piro OE; Leite CQ; Pavan FR; Gambino D Eur J Med Chem; 2014 Nov; 87():267-73. PubMed ID: 25261824 [TBL] [Abstract][Full Text] [Related]
11. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria. Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides. Rai D; Johar M; Srivastav NC; Manning T; Agrawal B; Kunimoto DY; Kumar R J Med Chem; 2007 Sep; 50(19):4766-74. PubMed ID: 17696514 [TBL] [Abstract][Full Text] [Related]
13. Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 System. Rodrigues C; Jani J; Shenai S; Thakkar P; Siddiqi S; Mehta A Int J Tuberc Lung Dis; 2008 Dec; 12(12):1449-55. PubMed ID: 19017456 [TBL] [Abstract][Full Text] [Related]
14. Iron enhances the antituberculous activity of pyrazinamide. Somoskovi A; Wade MM; Sun Z; Zhang Y J Antimicrob Chemother; 2004 Feb; 53(2):192-6. PubMed ID: 14729751 [TBL] [Abstract][Full Text] [Related]
15. [Investigation of rpsL and rrs gene region mutations in streptomycin resistant Mycobacterium tuberculosis complex isolates]. Ulger M; Aslan G; Emekdaş G; Tezcan S; Serin MS Mikrobiyol Bul; 2009 Jan; 43(1):115-20. PubMed ID: 19334387 [TBL] [Abstract][Full Text] [Related]
16. A comparison of conventional and radiometric methods for the assessment of anti-tubercular activity of drugs against Mycobacterium tuberculosis in mice and macrophage models. Jhamb SS; Singh RP; Singh PP Indian J Tuberc; 2008 Apr; 55(2):70-6. PubMed ID: 18516822 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and antituberculosis activity of new hydrazide derivatives. Kaplancikli ZA; Turan-Zitouni G; Ozdemir A; Teulade JC Arch Pharm (Weinheim); 2008 Nov; 341(11):721-4. PubMed ID: 18720343 [TBL] [Abstract][Full Text] [Related]
18. Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2'-arabinofuranosyl and 1-(2'-deoxy-2'-fluoro-beta-D-2'-ribofuranosyl) pyrimidine nucleoside analogs. Johar M; Manning T; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R J Med Chem; 2007 Jul; 50(15):3696-705. PubMed ID: 17602465 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the BacT/ALERT PZA kit in comparison with the BACTEC 460TB PZA for testing Mycobacterium tuberculosis susceptibility to pyrazinamide. Aragón LM; Garrigó M; Moreno C; Español M; Coll P J Antimicrob Chemother; 2007 Sep; 60(3):655-7. PubMed ID: 17615155 [TBL] [Abstract][Full Text] [Related]
20. Diospyrone, crassiflorone and plumbagin: three antimycobacterial and antigonorrhoeal naphthoquinones from two Diospyros spp. Kuete V; Tangmouo JG; Meyer JJ; Lall N Int J Antimicrob Agents; 2009 Oct; 34(4):322-5. PubMed ID: 19505805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]